When accurate diagnoses and treatments are delayed, patients pay the price—clinically, financially, and emotionally. While it’s not a panacea for all the challenges patients face, this white paper explores how life science marketers can be part of the solution through smarter HCP and DTC marketing strategies.
White Paper: The Marketer's Role in Earlier Disease Intervention
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
Stay Informed and Connected.
Search Resources
All topics
48550987443
All dates
White Paper: The Marketer's Role in Earlier Disease Intervention
When accurate diagnoses and treatments are delayed, patients pay the price—clinically, financially, and emotionally. While it’s not a panacea for all the challenges patients face, this white paper explores how life science marketers can be part of the solution through smarter HCP and DTC marketing strategies.
Omnichannel Marketing in Pharma Finally Works: The Precision Change
For years, “omnichannel” has been one of the most overused words in pharmaceutical marketing. Yet for many brands, it has delivered underwhelming results. Campaigns were launched with good intentions—reach patients everywhere, reinforce messages with HCPs, influence decisions across the journey—but the execution often relied on disconnected tactics, incomplete data, and static audiences that didn’t reflect real patient needs.
Reimagine Out of Home Media as a Strategic, Data-Driven Channel
The big news: media buyers no longer need to give up transparency and precision when including OOH/DOOH in their media plans, even when you’re not buying programmatically. Recently, our partner, Lamar Advertising, announced “Health Connect,” a healthcare-focused audience marketplace. It’s built to make out of home media perform like a data-driven digital channel, but with the privacy, credibility, and physical visibility that pharma marketers need right now.